CTRI/2022/10/046686尚未招募未知
Clinical profile and multimodal imaging characteristics of Macular Telangiectasia Type 2 in Indian population
Aravind Eye Hospital Chennai0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All consecutive patients with clinical suspicion of Macular Telangiectasia Type 2 above 30 years of age attending Aravind Eye Hospital Out Patient Department
排除标准
- •co-existing macular pathology
- •prior vitreoretina surgery
- •severe media opacity precluding grading of image
- •pregnant and lactating women
研究者
相似试验
已完成
1 期
The study is to assess the retinal biomarkers in patients diagnosed with macular telangiectasia.CTRI/2018/03/012742Giridhar Eye Institute25
已完成
不适用
Multimodal Model Predicts RecurrenceGastric AdenocarcinomaNCT06690268Qun Zhao93
招募中
不适用
The value of clinical factors, imaging features and biological characteristics for the prediction of outcome after radiotherapy in larynx cancer.NL-OMON28459Maastro Clinic400
招募中
不适用
Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary SyndromeChronic Coronary SyndromeNCT06261866Medical University of Warsaw200
进行中（未招募）
1 期
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2015-000519-42-ITIVERIC bio, Inc.32